Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous plus intramyometrial oxytocin vs intravenous carbetocin during cesarean section to prevent postpartum hemorrhage
TCTR20190829003Phase 3Completed
- Sponsor
- Department of Medical Services
- Start
- Jul 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in postpartum hemorrhage (PPH) comparing Intravenous plus intramyometrial oxytocin with Intravenous carbetocin (2 arms). Started Jul 2019; status: completed.
02
Drugs
oxytocincarbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on TCTR20190829003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190829003.